Welcome to our dedicated page for Kraig Biocraft Laboratories In news (Ticker: KBLB), a resource for investors and traders seeking the latest updates and insights on Kraig Biocraft Laboratories In stock.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) regularly issues detailed news releases about its work in recombinant spider silk and bioengineered fibers. The company describes itself as a world leader in spider silk technology and uses its news flow to report on production milestones, facility expansions, scientific progress, and commercial engagements.
News items often highlight advances in the company’s BAM-1 and BAM-1 Alpha hybrid silkworm lines, including selective breeding achievements that increase cocoon shell weight, throughput, and production efficiency. Kraig Biocraft Laboratories also reports on the launch and completion of spider silk production cycles, the deployment of BAM-1 Alpha as its primary production hybrid, and the integration of diapause egg management into its rearing operations.
Another recurring theme in KBLB news is the build-out of production infrastructure in Southeast Asia. Releases cover topics such as taking possession of additional silkworm rearing centers, relocating facilities to protected highlands, and maintaining multiple, parallel production sites to support scalability and resilience. The company also reports on securing usage rights to government-owned mulberry gardens and taking control of mulberry fields dedicated to its operations, emphasizing feedstock security and vertical coordination.
Investors and observers can also find updates on commercial and research developments, including pilot programs with a globally recognized performance sports apparel brand and announcements about scientific leadership and breakthroughs in advanced fibers and bioengineered materials. Together, these news items provide an ongoing view into Kraig Biocraft Laboratories’ efforts to expand spider silk production capacity, refine its technology, and pursue high-value applications in performance textiles, technical apparel, and other markets.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) announced the delivery of the first two hybrid-cross Dragon Silk™ strains to its production partner in Vietnam. This development addresses key challenges in large-scale production, enhancing the robustness of silkworms. The new strains combine the mechanical performance of Dragon Silk with local silkworm traits, increasing cocoon size and resilience. Kraig Labs is also pursuing a four-line hybrid-cross program to further improve yields. COO Jon Rice highlighted the progress in overcoming production scaling challenges, signaling potential increases in production capacity and efficiency.
Kraig Biocraft Laboratories (KBLB) announced the near completion of an $8 million convertible debenture with Yorkville Advisors, converting over 98% of this debt into equity. The company reports over $4.5 million in liquid assets, with only $150,000 remaining debt to Yorkville. The funds have been invested in expanding production facilities in Vietnam and enhancing R&D capabilities in the U.S. Kraig Labs aims to scale up spider silk production and develop innovative technologies, with a focus on strategic partnerships to meet market demand.
Kraig Biocraft Laboratories (OTCQB: KBLB) has engaged textile expert Jeff Dorton to enhance the development of innovative yarns and fabrics using Dragon Silk™. This partnership aims to revolutionize the textile industry, specifically through the launch of Spydasilk Enterprises in Singapore, the company's joint venture. Dorton brings extensive experience from brands like The North Face, focusing on sustainability and high-performance materials. The collaboration is expected to create several new textile applications, expanding Kraig Labs' market presence in luxury and performance textiles.
Kraig Biocraft Laboratories (KBLB) has been granted a business license to operate in Lam Dong Province, Vietnam, enhancing its efforts in spider silk production. This expansion leverages the region's ideal climate for silkworm rearing and existing silk production infrastructure. Notably, the Lam Dong Agro-Forestry Research Experiment Center is instrumental in boosting mulberry yields, which Kraig Labs has started utilizing, showing a doubled production capacity. The company maintains its headquarters in Quang Nam, where it produces proprietary silkworm eggs. COO Jon Rice expressed optimism about the integration of their technology into Vietnamese silk production.
Kraig Biocraft Laboratories (KBLB) has released a new video showcasing its recombinant spider silk production operations, providing insights into its U.S. R&D and Vietnam quality control labs. The video emphasizes the work of its dedicated researchers in creating cost-effective and eco-friendly spider silk products. COO Jon Rice highlighted the team's efforts in developing advanced materials. Future videos will explore breeding operations and the team behind these innovations.
Kraig Biocraft Laboratories (OTCQB: KBLB) attended the SaigonTex exhibition in Vietnam, marking its first major textile industry event since 2019 due to COVID-19. The SpydaSilk brand team aimed to expand its supplier network, focusing on creating unique yarns and fabrics from the company's recombinant spider silk technologies. COO Jon Rice expressed enthusiasm about the exhibition's return and its networking opportunities. The company is also set to release a new behind-the-scenes video next week about its spider silk production, emphasizing ongoing R&D efforts.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) released a video showcasing its advanced silkworm breeding facility in Vietnam. This facility is dedicated to producing eco-friendly spider silk and is expected to meet production demands through 2025.
The video marks the beginning of a series aimed at providing insights into the Company's recombinant spider silk production operations. Kraig Labs believes this facility is one of the most advanced in the world, enhancing their capacity for cost-effective production. Future videos will explore R&D labs and breeding operations.
Kraig Biocraft Laboratories, Inc. (KBLB) has signed its first third-party production contract for large-scale manufacturing of recombinant spider silk. Operations are set to begin immediately, with expectations of producing hundreds of kilograms per month and possibly reaching multiple metric tons by Q1 2023. The contractor, already equipped with Kraig's proprietary technology, will undergo a 90-day ramp-up for initial deliveries. Kraig Labs will gain minority ownership in the production facility, ensuring oversight of financial records and operations as they aim to deliver eco-friendly spider silk to the market.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has announced the successful development of new hybrid Dragon SilkTM silkworms aimed at enhancing large-scale production in Vietnam. These new breeds are designed to produce larger cocoons and longer silk filaments, which will significantly lower production costs and improve throughput. This initiative builds on the company's hybridization program initiated in 2018, resulting in silk cocoons that are 30-100% larger than traditional non-hybrid silkworms, thus facilitating a more consistent production platform.
Kraig Biocraft Laboratories (KBLB) has selected a high-quality garment manufacturer, in collaboration with its partner Kings Group, to produce its first apparel line using Spydasilk'sTM exclusive spider silk materials. The chosen manufacturer has over 20 years of experience and strong connections within Vietnam's textile supply chain, enabling it to deliver on the vision for the brand. Kraig Labs is simultaneously developing a product launch plan that includes marketing and distribution strategies, with expectations for further updates on production and market advancements.